因辅料聚山梨酯80引起的过敏反应。 - Suppr

Suppr

超能文献

Anaphylaxis Due to the Excipient Polysorbate 80.

作者信息

Palacios Castaño M I, Venturini Díaz M, Lobera Labairu T, González Mahave I, Del Pozo Gil M D, Blasco Sarramián A

机构信息

Servicio de Alergología, Hospital San Pedro, Logroño, Spain.

出版信息

J Investig Allergol Clin Immunol. 2016;26(6):394-396. doi: 10.18176/jiaci.0109.

DOI:10.18176/jiaci.0109

PMID:27996954

Abstract

摘要

相似文献

Anaphylaxis Due to the Excipient Polysorbate 80.

J Investig Allergol Clin Immunol. 2016;26(6):394-396. doi: 10.18176/jiaci.0109.

Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate.

Ann Allergy Asthma Immunol. 2018 Jun;120(6):664-666. doi: 10.1016/j.anai.2018.02.018. Epub 2018 Feb 23.

IgE-Mediated Anaphylaxis Induced by Macrogol 6000.

J Investig Allergol Clin Immunol. 2016;26(6):398-400. doi: 10.18176/jiaci.0089.

Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy.

Allergy Asthma Proc. 2007 May-Jun;28(3):313-9. doi: 10.2500/aap.2007.28.3003.

Anaphylaxis in a child after ingestion of persimmon.

J Investig Allergol Clin Immunol. 2015;25(2):142-4.

Vaginal Capsules: An Unsuspected Probable Source of Exposure to α-Gal.

J Investig Allergol Clin Immunol. 2016;26(6):388-389. doi: 10.18176/jiaci.0105.

Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines.

J Investig Allergol Clin Immunol. 2021 Feb 17;31(1):92-93. doi: 10.18176/jiaci.0667. Epub 2020 Jan 12.

[Indirect identification of hypersensitivity reaction to etoposide mediated by polysorbate 80].

Farm Hosp. 2018 Jan 1;42(1):27-28. doi: 10.7399/fh.10882.

Biologic excipients: Importance of clinical awareness of inactive ingredients.

PLoS One. 2020 Jun 25;15(6):e0235076. doi: 10.1371/journal.pone.0235076. eCollection 2020.

Broad Bean-Induced Anaphylaxis: A Case Report.

J Investig Allergol Clin Immunol. 2016;26(6):374-375. doi: 10.18176/jiaci.0096.

引用本文的文献

Challenges in diagnosing polyethylene glycol and polysorbate 80 allergies: implications for allergic reactions in COVID-19 mRNA vaccination program: experience from Qatar.

Front Allergy. 2025 Jan 7;5:1502285. doi: 10.3389/falgy.2024.1502285. eCollection 2024.

A Narrative Literature Review of the Established Safety of Human Serum Albumin Use as a Stabilizer in Aesthetic Botulinum Toxin Formulations Compared to Alternatives.

Toxins (Basel). 2023 Oct 18;15(10):619. doi: 10.3390/toxins15100619.

[Suspected allergy to COVID-19 vaccines: A retrospective study of 320 patients].

Rev Fr Allergol (2009). 2023 Mar;63(2):103303. doi: 10.1016/j.reval.2023.103303. Epub 2023 Jan 19.

Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates.

Pharmaceutics. 2022 Nov 23;14(12):2575. doi: 10.3390/pharmaceutics14122575.

Etoposide hypersensitivity reactions associated with in-line filter use: A retrospective cohort study at CHU de Québec-Université Laval.

J Oncol Pharm Pract. 2023 Oct;29(7):1687-1694. doi: 10.1177/10781552221146801. Epub 2022 Dec 21.

[Not Available].

Allergo J. 2022;31(5):40-43. doi: 10.1007/s15007-022-5055-2. Epub 2022 Jul 25.

New Challenges in Drug Allergy: the Resurgence of Excipients.

Curr Treat Options Allergy. 2022;9(3):273-291. doi: 10.1007/s40521-022-00313-6. Epub 2022 Jul 24.

Anaphylaxis to drug excipients.

Allergo J Int. 2022;31(5):137-140. doi: 10.1007/s40629-022-00214-9. Epub 2022 May 31.

COVID-19 Vaccine Anaphylaxis: Current Evidence and Future Approaches.

Front Allergy. 2021 Dec 23;2:801322. doi: 10.3389/falgy.2021.801322. eCollection 2021.

To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives.

Adv Drug Deliv Rev. 2022 Jan;180:114079. doi: 10.1016/j.addr.2021.114079. Epub 2021 Dec 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Anaphylaxis Due to the Excipient Polysorbate 80.

J Investig Allergol Clin Immunol. 2016;26(6):394-396. doi: 10.18176/jiaci.0109.

Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate.

Ann Allergy Asthma Immunol. 2018 Jun;120(6):664-666. doi: 10.1016/j.anai.2018.02.018. Epub 2018 Feb 23.

IgE-Mediated Anaphylaxis Induced by Macrogol 6000.

J Investig Allergol Clin Immunol. 2016;26(6):398-400. doi: 10.18176/jiaci.0089.

Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy.

Allergy Asthma Proc. 2007 May-Jun;28(3):313-9. doi: 10.2500/aap.2007.28.3003.

Anaphylaxis in a child after ingestion of persimmon.

J Investig Allergol Clin Immunol. 2015;25(2):142-4.

Vaginal Capsules: An Unsuspected Probable Source of Exposure to α-Gal.

J Investig Allergol Clin Immunol. 2016;26(6):388-389. doi: 10.18176/jiaci.0105.

Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines.

J Investig Allergol Clin Immunol. 2021 Feb 17;31(1):92-93. doi: 10.18176/jiaci.0667. Epub 2020 Jan 12.

[Indirect identification of hypersensitivity reaction to etoposide mediated by polysorbate 80].

Farm Hosp. 2018 Jan 1;42(1):27-28. doi: 10.7399/fh.10882.

Biologic excipients: Importance of clinical awareness of inactive ingredients.

PLoS One. 2020 Jun 25;15(6):e0235076. doi: 10.1371/journal.pone.0235076. eCollection 2020.

Broad Bean-Induced Anaphylaxis: A Case Report.

J Investig Allergol Clin Immunol. 2016;26(6):374-375. doi: 10.18176/jiaci.0096.

引用本文的文献

Challenges in diagnosing polyethylene glycol and polysorbate 80 allergies: implications for allergic reactions in COVID-19 mRNA vaccination program: experience from Qatar.

Front Allergy. 2025 Jan 7;5:1502285. doi: 10.3389/falgy.2024.1502285. eCollection 2024.

A Narrative Literature Review of the Established Safety of Human Serum Albumin Use as a Stabilizer in Aesthetic Botulinum Toxin Formulations Compared to Alternatives.

Toxins (Basel). 2023 Oct 18;15(10):619. doi: 10.3390/toxins15100619.

[Suspected allergy to COVID-19 vaccines: A retrospective study of 320 patients].

Rev Fr Allergol (2009). 2023 Mar;63(2):103303. doi: 10.1016/j.reval.2023.103303. Epub 2023 Jan 19.

Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates.

Pharmaceutics. 2022 Nov 23;14(12):2575. doi: 10.3390/pharmaceutics14122575.

Etoposide hypersensitivity reactions associated with in-line filter use: A retrospective cohort study at CHU de Québec-Université Laval.

J Oncol Pharm Pract. 2023 Oct;29(7):1687-1694. doi: 10.1177/10781552221146801. Epub 2022 Dec 21.

[Not Available].

Allergo J. 2022;31(5):40-43. doi: 10.1007/s15007-022-5055-2. Epub 2022 Jul 25.

New Challenges in Drug Allergy: the Resurgence of Excipients.

Curr Treat Options Allergy. 2022;9(3):273-291. doi: 10.1007/s40521-022-00313-6. Epub 2022 Jul 24.

Anaphylaxis to drug excipients.

Allergo J Int. 2022;31(5):137-140. doi: 10.1007/s40629-022-00214-9. Epub 2022 May 31.

COVID-19 Vaccine Anaphylaxis: Current Evidence and Future Approaches.

Front Allergy. 2021 Dec 23;2:801322. doi: 10.3389/falgy.2021.801322. eCollection 2021.

To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives.

Adv Drug Deliv Rev. 2022 Jan;180:114079. doi: 10.1016/j.addr.2021.114079. Epub 2021 Dec 10.